Cohen & Steers, Inc. (CNS)

NYSE: CNS · Real-Time Price · USD
82.27
+0.70 (0.86%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Market Cap4.23B +12.5%
Revenue (ttm)583.89M +7.4%
Net Income168.30M +3.8%
EPS3.25 +3.3%
Shares Out 51.42M
PE Ratio25.31
Forward PE22.30
Dividend$2.68 (3.26%)
Ex-Dividend DateAug 10, 2026
Volume208,364
Open82.24
Previous Close81.57
Day's Range80.21 - 82.30
52-Week Range58.39 - 84.93
Beta1.21
AnalystsHold
Price Target73.67 (-10.45%)
Earnings DateJul 16, 2026

About CNS

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equ... [Read more]

Sector Financials
IPO Date Aug 13, 2004
Employees 424
Stock Exchange NYSE
Ticker Symbol CNS
Full Company Profile

Financial Performance

In 2025, Cohen & Steers's revenue was $556.12 million, an increase of 7.48% compared to the previous year's $517.42 million. Earnings were $153.22 million, an increase of 1.29%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for CNS stock is "Hold." The 12-month stock price target is $73.67, which is a decrease of -10.45% from the latest price.

Price Target
$73.67
(-10.45% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Cohen & Steers, Inc. Declares Quarterly Dividend

NEW YORK, July 30, 2026 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the third quarter of 2026 in the amount of $0.67 per share of common sto...

2 days ago - PRNewsWire

Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy

NEW YORK, July 29, 2026 /PRNewswire/ -- Cohen & Steers Closed-end Opportunity Fund, Inc. (NYSE:FOF) (the "Fund"), announced today that the Fund's Board of Directors has approved certain changes to the...

Other symbols: FOF
3 days ago - PRNewsWire

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of ...

Other symbols: FOF
4 days ago - PRNewsWire

Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the...

Other symbols: RFI
4 days ago - PRNewsWire

Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sour...

Other symbols: RNP
4 days ago - PRNewsWire

Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of t...

Other symbols: RQI
4 days ago - PRNewsWire

Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dist...

Other symbols: UTF
4 days ago - PRNewsWire

Cohen & Steers names Erik Schneberger as Chief Marketing Officer

Cohen & Steers announced the appointment of Erik Schneberger as Executive Vice President, Chief Marketing Officer. Based in New York, Schneberger will lead the firm’s global marketing department, over...

13 days ago - TheFly

Cohen & Steers Appoints Erik Schneberger as Chief Marketing Officer

NEW YORK, July 20, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the appointment of Erik Schneberger as Executive Vice President, Chief Marketing Officer. Based in New York, Mr...

13 days ago - PRNewsWire

Cohen & Steers Earnings Call Transcript: Q2 2026

Adjusted EPS rose to $0.85 with net income up 18% year-over-year and AUM surpassing $100 billion, driven by strong net inflows and robust performance in real estate, preferreds, and infrastructure. Strategic growth initiatives and international expansion continued, with positive outlook for real assets.

16 days ago - Transcripts

Cohen & Steers Slides: Q2 2026

Cohen & Steers has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 17, 2026.

16 days ago - Filings

Cohen & Steers Earnings release: Q2 2026

Cohen & Steers released its Q2 2026 earnings on July 17, 2026, summarizing the period's financial results.

16 days ago - Filings

Cohen & Steers Quarterly report: Q2 2026

Cohen & Steers has published its Q2 2026 quarterly earnings report on July 17, 2026.

16 days ago - Filings

COHEN & STEERS REPORTS RESULTS FOR SECOND QUARTER 2026

NEW YORK, July 16, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the quarter ended June 30, 2026. The earnings release along with the accompanying earnings prese...

16 days ago - PRNewsWire

Cohen & Steers Quality Income Realty Fund, Inc. Announces Preliminary Results of Transferable Rights Offering

NEW YORK, July 16, 2026 /PRNewswire/ -- Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") today announced the results of its transferable rights offering (the "Offer"), which co...

Other symbols: RQI
17 days ago - PRNewsWire

Cohen & Steers price target raised to $84 from $82 at Evercore ISI

Evercore ISI analyst John Dunn raised the firm’s price target on Cohen & Steers to $84 from $82 and keeps an Outperform rating on the shares. Cohen & Steers reported…

23 days ago - TheFly

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for June 2026

NEW YORK, July 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $100.1 billion as of June 30, 2026, an increase of $644 million from asset...

23 days ago - PRNewsWire

Cohen & Steers, Inc. to Release Second Quarter 2026 Results on July 16, 2026

NEW YORK, July 8, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced that it expects to release second quarter 2026 results after the market closes on Thursday, July 16, 2026. The earning...

24 days ago - PRNewsWire

MapLight Therapeutics Announces Changes to Board of Directors

SAN FRANCISCO and BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering ...

Other symbols: MPLT
5 weeks ago - GlobeNewsWire

Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th

CUPERTINO, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that see...

5 weeks ago - GlobeNewsWire

Cohen & Steers Closed-End Funds Declare Distributions for July, August and September 2026

NEW YORK, June 22, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for July, August and September 2026, as summarized in th...

5 weeks ago - PRNewsWire

Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

CAMBRIDGE, Mass., June 22, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceutica...

5 weeks ago - PRNewsWire

Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today an...

Other symbols: AXSM
6 weeks ago - GlobeNewsWire

Latus Bio Appoints Bethany Mancilla as Chief Business Officer

PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the appointment of Bethany Mancilla as Chief Business Offi...

6 weeks ago - Business Wire

Cohen & Steers Completes Conversion of Future of Energy Mutual Fund to Active ETF

NEW YORK, June 15, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced it has completed the conversion the Cohen & Steers Future of Energy Fund (MLOIX) into a new, actively managed e...

6 weeks ago - PRNewsWire